|
|
||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||





* Department of Physiology, University of Tübingen, Tübingen, Germany;
Department of Dermatology, University of Tübingen, Tübingen, Germany; and
Center for Molecular Neurobiology, Institute for Molecular and Cellular Cognition, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
The PI3K pathway plays a pivotal role in the stimulation of mast cells. PI3K-dependent kinases include the serum- and glucocorticoid-inducible kinase 1 (SGK1). The present study explored the role of SGK1 in mast cell function. Mast cells were isolated from bone marrow (BMMC) of SGK1 knockout mice (sgk1–/–) and their wild-type littermates (sgk1+/+). The BMMC number as well as CD117, CD34, and Fc
RI expression in BMCCs were similar in both genotypes. Upon Ag stimulation of the Fc
RI receptor, Ca2+ entry but not Ca2+ release from intracellular stores was markedly impaired in sgk1–/– BMMCs. The currents through Ca2+-activated K+ channels induced by Ag were significantly higher in sgk1+/+ BMMCs than in sgk1–/– BMMCs. Treatment with the Ca2+ ionophore ionomycin (1 µM) led to activation of the K+ channels in both genotypes, indicating that the Ca2+-activated K+ channels are similarly expressed and sensitive to activation by Ca2+ in sgk1+/+ and sgk1–/– BMMCs, and that blunted stimulation of Ca2+-activated K+ channels was secondary to decreased Ca2+ entry. Ag-IgE-induced degranulation and early IL-6 secretion were also significantly blunted in sgk1–/– BMMCs. The decrease in body temperature following Ag treatment, which reflects an anaphylactic reaction, was substantially reduced in sgk1–/– mice, pointing to impaired mast cell function in vivo. Serum histamine levels measured 30 min after induction of an anaphylactic reaction were significantly lower in sgk1–/– than in sgk1+/+mice. The observations reveal a critical role for SGK1 in ion channel regulation and the function of mast cells, and thus disclose a completely novel player in the regulation of allergic reaction.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Deutsche Forschungsgemeinschaft (Grants SFB 766, SFB 685 A6, Bi 696/5-1, and Bi 696/3-1), the International Graduate School (Grant GRK 1302/1), The PI3K Pathway in Tumor Growth and Diabetes, and the FORTÜNE program of the University of Tübingen.
2 Contributed equally to the work and thus share first authorship.
3 Current address: Department of Molecular Neurogenetics, Max Planck Institute of Biophysics, Max-von-Laue Strasse 3, D-60438 Frankfurt am Main, Germany.
4 Address correspondence and reprint requests to Dr. Florian Lang or Dr. Tilo Biedermann, Department of Physiology, University of Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany. E-mail address: florian.lang{at}uni-tuebingen.de or Department of Dermatology, University of Tübingen, Liebermeisterstrasse 25, D-72076 Tübingen, Germany. E-mail address: tilo.biedermann{at}med.uni-tuebingen.de
5 Abbreviations used in this paper: SGK1, serum- and glucocorticoid-inducible kinase-1; BMMC, bone marrow-derived mast cell; DNP-HSA, DNP-human serum albumin; TNCB, trinitrochlorobenzene; TRPV2, transient receptor potential cation channel, subfamily V, member 2; PDK1, phosphoinositide-dependent kinase.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |